| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Cell and Tumor Biology |
Departments of 1 Cancer Research, 2 Structural Biology, and 3 Molecular Biology, Abbott Laboratories, Abbott Park, Illinois
Requests for reprints: Don Davidson, Department of Cancer Research, Abbott Laboratories, Department 48R, Building AP9, 100 Abbott Park Road, Abbott Park, IL 60064. Phone: 847-937-8547; Fax: 847-937-4150; E-mail: don.j.davidson{at}abbott.com.
Kringle 5 (K5) of human plasminogen has been shown to inhibit angiogenesis by inducing the apoptosis of proliferating endothelial cells. Peptide regions around the lysine-binding pocket of K5 largely mediate these effects, particularly the peptide PRKLYDY, which we show to compete with K5 for the binding to endothelial cells. The cell surface binding site for K5 that mediates these effects has not been defined previously. Here, we report that glucose-regulated protein 78, exposed on cell surfaces of proliferating endothelial cells as well as on stressed tumor cells, plays a key role in the antiangiogenic and antitumor activity of K5. We also report that recombinant K5-induced apoptosis of stressed HT1080 fibrosarcoma cells involves enhanced activity of caspase-7, consistent with the disruption of glucose-regulated protein 78-procaspase-7 complexes. These results establish recombinant K5 as an inhibitor of a stress response pathway, which leads to both endothelial and tumor cell apoptosis.
This article has been cited by other articles:
|
|
 |
|
  A. Laverriere, R. Landau, I. Charvet, O. Irion, P. Bischof, M. Morales, and M. Cohen GRP78 as a marker of pre-eclampsia: an exploratory study Mol. Hum. Reprod., September 1, 2009; 15(9): 569 - 574. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. C. McFarland, J. Stewart Jr., A. Hamza, R. Nordal, D. J. Davidson, J. Henkin, and C. L. Gladson Plasminogen Kringle 5 Induces Apoptosis of Brain Microvessel Endothelial Cells: Sensitization by Radiation and Requirement for GRP78 and LRP1 Cancer Res., July 1, 2009; 69(13): 5537 - 5545. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Baumeister, D. Dong, Y. Fu, and A. S. Lee Transcriptional induction of GRP78/BiP by histone deacetylase inhibitors and resistance to histone deacetylase inhibitor-induced apoptosis Mol. Cancer Ther., May 1, 2009; 8(5): 1086 - 1094. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Bressenot, S. Marchal, L. Bezdetnaya, J. Garrier, F. Guillemin, and F. Plenat Assessment of Apoptosis by Immunohistochemistry to Active Caspase-3, Active Caspase-7, or Cleaved PARP in Monolayer Cells and Spheroid and Subcutaneous Xenografts of Human Carcinoma J. Histochem. Cytochem., April 1, 2009; 57(4): 289 - 300. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. J. Virrey, D. Dong, C. Stiles, J. B. Patterson, L. Pen, M. Ni, A. H. Schonthal, T. C. Chen, F. M. Hofman, and A. S. Lee Stress Chaperone GRP78/BiP Confers Chemoresistance to Tumor-Associated Endothelial Cells Mol. Cancer Res., August 1, 2008; 6(8): 1268 - 1275. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H.-K. Kim, D.-S. Oh, S.-B. Lee, J.-M. Ha, and Y. A. Joe Antimigratory effect of TK1-2 is mediated in part by interfering with integrin {alpha}2{beta}1 Mol. Cancer Ther., July 1, 2008; 7(7): 2133 - 2141. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Philippova, D. Ivanov, M. B. Joshi, E. Kyriakakis, K. Rupp, T. Afonyushkin, V. Bochkov, P. Erne, and T. J. Resink Identification of Proteins Associating with Glycosylphosphatidylinositol- Anchored T-Cadherin on the Surface of Vascular Endothelial Cells: Role for Grp78/BiP in T-Cadherin-Dependent Cell Survival Mol. Cell. Biol., June 15, 2008; 28(12): 4004 - 4017. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Dong, M. Ni, J. Li, S. Xiong, W. Ye, J. J. Virrey, C. Mao, R. Ye, M. Wang, L. Pen, et al. Critical Role of the Stress Chaperone GRP78/BiP in Tumor Proliferation, Survival, and Tumor Angiogenesis in Transgene-Induced Mammary Tumor Development Cancer Res., January 15, 2008; 68(2): 498 - 505. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Shani, W. H. Fischer, N. J. Justice, J. A. Kelber, W. Vale, and P. C. Gray GRP78 and Cripto Form a Complex at the Cell Surface and Collaborate To Inhibit Transforming Growth Factor Signaling and Enhance Cell Growth Mol. Cell. Biol., January 15, 2008; 28(2): 666 - 677. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Gonzalez-Gronow, S. J. Kaczowka, S. Payne, F. Wang, G. Gawdi, and S. V. Pizzo Plasminogen Structural Domains Exhibit Different Functions When Associated with Cell Surface GRP78 or the Voltage-dependent Anion Channel J. Biol. Chem., November 9, 2007; 282(45): 32811 - 32820. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. W. Graner, R. I. Cumming, and D. D. Bigner The Heat Shock Response and Chaperones/Heat Shock Proteins in Brain Tumors: Surface Expression, Release, and Possible Immune Consequences J. Neurosci., October 17, 2007; 27(42): 11214 - 11227. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Pyrko, A. H. Schonthal, F. M. Hofman, T. C. Chen, and A. S. Lee The Unfolded Protein Response Regulator GRP78/BiP as a Novel Target for Increasing Chemosensitivity in Malignant Gliomas Cancer Res., October 15, 2007; 67(20): 9809 - 9816. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. G. Jakobsen, N. Rasmussen, A.-V. Laenkholm, and H. J. Ditzel Phage Display Derived Human Monoclonal Antibodies Isolated by Binding to the Surface of Live Primary Breast Cancer Cells Recognize GRP78 Cancer Res., October 1, 2007; 67(19): 9507 - 9517. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Zou, Y. Chen, Y. Jiang, J. Gao, and J. Gu Targeting Matrix Metalloproteinases and Endothelial Cells with a Fusion Peptide against Tumor Cancer Res., August 1, 2007; 67(15): 7295 - 7300. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. M. B. Nguyen, I. V. Subramanian, A. Kelekar, and S. Ramakrishnan Kringle 5 of human plasminogen, an angiogenesis inhibitor, induces both autophagy and apoptotic death in endothelial cells Blood, June 1, 2007; 109(11): 4793 - 4802. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. S. Lee GRP78 Induction in Cancer: Therapeutic and Prognostic Implications Cancer Res., April 15, 2007; 67(8): 3496 - 3499. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Fu, J. Li, and A. S. Lee GRP78/BiP Inhibits Endoplasmic Reticulum BIK and Protects Human Breast Cancer Cells against Estrogen Starvation-Induced Apoptosis Cancer Res., April 15, 2007; 67(8): 3734 - 3740. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. R. Perri, D. Martineau, M. Francois, L. Lejeune, L. Bisson, Y. Durocher, and J. Galipeau Plasminogen Kringle 5 blocks tumor progression by antiangiogenic and proinflammatory pathways Mol. Cancer Ther., February 1, 2007; 6(2): 441 - 449. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. Schmitz, E. Raskopf, M. A. Gonzalez-Carmona, A. Vogt, C. Rabe, L. Leifeld, M. Kornek, T. Sauerbruch, and W. H Caselmann Plasminogen fragment K1-5 improves survival in a murine hepatocellular carcinoma model Gut, February 1, 2007; 56(2): 271 - 278. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Luo, C. Mao, B. Lee, and A. S. Lee GRP78/BiP Is Required for Cell Proliferation and Protecting the Inner Cell Mass from Apoptosis during Early Mouse Embryonic Development Mol. Cell. Biol., August 1, 2006; 26(15): 5688 - 5697. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. L. Chi and S. V. Pizzo Angiostatin Is Directly Cytotoxic to Tumor Cells at Low Extracellular pH: A Mechanism Dependent on Cell Surface-Associated ATP Synthase Cancer Res., January 15, 2006; 66(2): 875 - 882. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |
